Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Bioorg Med Chem ; 27(8): 1449-1455, 2019 04 15.
Article in English | MEDLINE | ID: mdl-30528164

ABSTRACT

Extracellular adenosine 5'-triphosphate (ATP) triggers the P2X7 receptor (P2X7R) ionic channel to stimulate the release of the interleukin-IL-1ß cytokine into macrophages. The current study explored the reaction of six structurally diverse triazole derivatives on P2X7-mediated dye uptake into murine peritoneal macrophages. P2X7R activity determined by ATP-evoked fluorescent dye uptake. Triazole derivatives toxicity measured using dextran rhodamine exclusion based colorimetric assay. A740004 and BBG, both P2X7R antagonist, inhibited ATP-induced dye uptake. In contrast, the derivatives 5a, 5b, 5e, and 5f did not diminish P2X7R activity in concentrations until 100 µM. 5c and 5d analogs caused a potent inhibitory activity on P2X7-induced dye uptake. Dextran Rhodamine exclusion measurements after 24 h of continuous treatment with triazole derivatives indicated a moderated toxicity for all molecules. In conclusion, this study showed that a series of new hybrid 1,2,3-triazolic naphthoquinones reduces P2X7R-induced dye uptake into murine macrophages. In silico analysis indicates a good pharmacokinetic profile and molecular docking results of these analogs indicate the potential to bind into an allosteric site located into the P2X7R pore and juxtaposed with the ATP binding pocket. In this manner, the compounds 5c and 5d may be used as a scaffold for new P2X7R inhibitors with reduced toxicity, and good anti-inflammatory activity.


Subject(s)
Naphthoquinones/chemistry , Purinergic P2X Receptor Antagonists/chemistry , Receptors, Purinergic P2X7/metabolism , Triazoles/chemistry , Allosteric Site , Animals , Binding Sites , Caco-2 Cells , Cell Line , Coloring Agents/metabolism , Humans , Macrophages/cytology , Macrophages/metabolism , Mice , Microsomes, Liver/metabolism , Molecular Docking Simulation , Permeability/drug effects , Protein Structure, Tertiary , Purinergic P2X Receptor Antagonists/metabolism , Purinergic P2X Receptor Antagonists/pharmacology , Receptors, Purinergic P2X7/chemistry , Triazoles/metabolism , Triazoles/pharmacology
2.
J Bioenerg Biomembr ; 50(4): 307-313, 2018 08.
Article in English | MEDLINE | ID: mdl-29882206

ABSTRACT

Purinergic receptors are widespread in the human organism and are involved in several physiological functions like neurotransmission, nociception, platelet aggregation, etc. In the immune system, they may regulate the expression and release of pro-inflammatory factors as well as the activation and death of several cell types. It is already described the participation of some purinergic receptors in the inflammation and pathological processes, such as a few neglected tropical diseases (NTDs) which affect more than 1 billion people in the world. Although the high social influence those diseases represent endemic countries, most of them do not have an efficient, safe or affordable drug treatment. In that way, this review aims to discuss the current literature involving purinergic receptor and immune response to NTDs pathogens, which may contribute in the search for new therapeutic possibilities.


Subject(s)
Neglected Diseases/drug therapy , Receptors, Purinergic/metabolism , Tropical Medicine/methods , Animals , Humans , Immunity , Inflammation , Molecular Targeted Therapy/methods , Neglected Diseases/immunology , Neglected Diseases/pathology , Signal Transduction/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...